KSB Ltd posted revenue of Rs 1,292 crore and an EBITDA of Rs 146.5 crore for H1 2026. While geopolitical tensions and project delays weighed on performance, the company reports a strong order book of Rs 2,744.5 crore, bolstered by a significant nuclear sector pipeline. Management expects momentum to pick up in the second half of the year as supply chain stability improves and test schedules for key nuclear projects resume.
KSB Ltd Reports H1 Revenue of Rs 1,292 Crore
Reported Revenue: Rs 1,292 crore | Orders on Hand: Rs 2,744.5 crore
Reader Takeaway: Robust nuclear order book supports long-term outlook despite short-term geopolitical headwinds and project execution delays.
What just happened
KSB Ltd has disclosed its financial performance for the first half of 2026, reporting a revenue of Rs 1,292 crore and an EBITDA of Rs 1,465 million. The company's total order book stands at Rs 2,744.5 crore, with the nuclear segment alone contributing Rs 1,235 crore. Performance in H1 was characterized as subdued, largely attributed to geopolitical tensions affecting export volumes and delays in testing schedules for critical nuclear projects.
Why this matters
As a player in the energy, oil, gas, and nuclear infrastructure space, KSB's performance reflects broader industrial capital expenditure trends. The company’s ability to navigate testing delays at NPCIL test beds for the GHAVP project is a primary driver for near-term revenue recognition. Investors should note the 20% capacity expansion at the Shirwal facility, which positions the company to meet future demand across its core segments.
What changes now
Management is prioritizing a return to double-digit growth in the second half of the year. The company is actively diversifying its infrastructure footprint into water, wastewater, railways, and data centers. Additionally, an upcoming implementation of SAP HANA is scheduled for early next year, which will involve increased operational expenditure.
Risks to watch
Key risks include the sensitivity of nuclear project execution to documentation and test bed availability. Furthermore, the valve segment has faced margin pressure from commodity price volatility and shifts in product mix. Geopolitical conflicts remain a significant variable that could impact the predictability of the export business.
What to track next
The primary focus for investors should be the resumption of testing for the GHAVP project in September 2026 and the pace of order execution in the export business. Recovery in the solar business, following delays in the KUSUM 2.0 scheme, is also expected to be a performance indicator for Q3 and Q4.